Antharis Therapeutics
Pre-clinicalImprove therapeutic outcomes with Antharis, a revolutionary platform that delivers unprecedented numbers and success rates in monoclonal antibody innovation.
Founded
2022
Focus
AntibodiesBiologics
About
Improve therapeutic outcomes with Antharis, a revolutionary platform that delivers unprecedented numbers and success rates in monoclonal antibody innovation.
Funding History
2Total raised: $24M
Series A$20MUndisclosedFeb 15, 2023
Seed$4MUndisclosedMay 15, 2021
Company Info
TypePrivate
Founded2022
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile